Patents by Inventor Charles Vaske

Charles Vaske has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230340609
    Abstract: Provided in part are techniques for cancer detection, monitoring, and reporting from sequencing cell-free DNA in plasma samples. Such detection can be informed from patient-specific circulating tumor cell (CTC) somatic genomic, epigenetic, and/or transcriptomic modifications. These techniques can be used to aid treatment decision support, diagnosis, and/or prognosis of cancer.
    Type: Application
    Filed: July 20, 2021
    Publication date: October 26, 2023
    Inventors: Kelly M. HARKINS KINCAID, Charles VASKE
  • Publication number: 20220403413
    Abstract: Systems and methods are presented that allow for determination and prediction of payload toxicity in therapeutic viruses. Disclosed herein are methods of determining payload toxicity of an expressed polypeptide in a cell, comprising: generating or procuring a plurality of expression vectors, each containing a different recombinant nucleic acid sequence that encodes a corresponding recombinant polypeptide; expressing the recombinant nucleic acid sequence in a plurality of host cells while culturing the host cells; sequencing the plurality of expression vectors after culturing the host cells; and correlating at least portions of the recombinant nucleic acid sequence with a toxicity measure.
    Type: Application
    Filed: July 24, 2020
    Publication date: December 22, 2022
    Applicants: Nantomics, LLC, NantBio, Inc.
    Inventors: Kamil Wnuk, Lise Geissert, Jeremi Sudol, Charles Vaske, Stephen Charles Benz, Connie Tsai, Kayvan Niazi, Christopher W. Szeto
  • Patent number: 10748056
    Abstract: Techniques are provided for predicting DNA accessibility. DNase-seq data files and RNA-seq data files for a plurality of cell types are paired by assigning DNase-seq data files to RNA-seq data files that are at least within a same biotype. A neural network is configured to be trained using batches of the paired data files, where configuring the neural network comprises configuring convolutional layers to process a first input comprising DNA sequence data from a paired data file to generate a convolved output, and fully connected layers following the convolutional layers to concatenate the convolved output with a second input comprising gene expression levels derived from RNA-seq data from the paired data file and process the concatenation to generate a DNA accessibility prediction output. The trained neural network is used to predict DNA accessibility in a genomic sample input comprising RNA-seq data and whole genome sequencing for a new cell type.
    Type: Grant
    Filed: September 3, 2019
    Date of Patent: August 18, 2020
    Assignees: NantOmics, LLC, Nant Holdings IP, LLC
    Inventors: Kamil Wnuk, Jeremi Sudol, Shahrooz Rabizadeh, Patrick Soon-Shiong, Christopher Szeto, Charles Vaske
  • Publication number: 20190392288
    Abstract: Techniques are provided for predicting DNA accessibility. DNase-seq data files and RNA-seq data files for a plurality of cell types are paired by assigning DNase-seq data files to RNA-seq data files that are at least within a same biotype. A neural network is configured to be trained using batches of the paired data files, where configuring the neural network comprises configuring convolutional layers to process a first input comprising DNA sequence data from a paired data file to generate a convolved output, and fully connected layers following the convolutional layers to concatenate the convolved output with a second input comprising gene expression levels derived from RNA-seq data from the paired data file and process the concatenation to generate a DNA accessibility prediction output. The trained neural network is used to predict DNA accessibility in a genomic sample input comprising RNA-seq data and whole genome sequencing for a new cell type.
    Type: Application
    Filed: September 3, 2019
    Publication date: December 26, 2019
    Applicants: NantOmics, LLC, Nant Holdings IP, LLC
    Inventors: Kamil Wnuk, Jeremi Sudol, Shahrooz Rabizadeh, Patrick Soon-Shiong, Christopher Szeto, Charles Vaske
  • Patent number: 10467523
    Abstract: Techniques are provided for predicting DNA accessibility. DNase-seq data files and RNA-seq data files for a plurality of cell types are paired by assigning DNase-seq data files to RNA-seq data files that are at least within a same biotype. A neural network is configured to be trained using batches of the paired data files, where configuring the neural network comprises configuring convolutional layers to process a first input comprising DNA sequence data from a paired data file to generate a convolved output, and fully connected layers following the convolutional layers to concatenate the convolved output with a second input comprising gene expression levels derived from RNA-seq data from the paired data file and process the concatenation to generate a DNA accessibility prediction output. The trained neural network is used to predict DNA accessibility in a genomic sample input comprising RNA-seq data and whole genome sequencing for a new cell type.
    Type: Grant
    Filed: November 20, 2017
    Date of Patent: November 5, 2019
    Assignees: Nant Holdings IP, LLC, NantOmics, LLP
    Inventors: Kamil Wnuk, Jeremi Sudol, Shahrooz Rabizadeh, Patrick Soon-Shiong, Christopher Szeto, Charles Vaske
  • Publication number: 20180144261
    Abstract: Techniques are provided for predicting DNA accessibility. DNase-seq data files and RNA-seq data files for a plurality of cell types are paired by assigning DNase-seq data files to RNA-seq data files that are at least within a same biotype. A neural network is configured to be trained using batches of the paired data files, where configuring the neural network comprises configuring convolutional layers to process a first input comprising DNA sequence data from a paired data file to generate a convolved output, and fully connected layers following the convolutional layers to concatenate the convolved output with a second input comprising gene expression levels derived from RNA-seq data from the paired data file and process the concatenation to generate a DNA accessibility prediction output. The trained neural network is used to predict DNA accessibility in a genomic sample input comprising RNA-seq data and whole genome sequencing for a new cell type.
    Type: Application
    Filed: November 20, 2017
    Publication date: May 24, 2018
    Applicants: NantOmics, LLC., Nant Holdings IP, LLC
    Inventors: Kamil Wnuk, Jeremi Sudol, Shahrooz Rabizadeh, Patrick Soon-Shiong, Christopher Szeto, Charles Vaske